Publications by authors named "Gijs J van Steenbergen"
Article Synopsis
- This study investigates the outcomes of patients who experience post-operative atrial fibrillation (POAF) after coronary artery bypass grafting (CABG) and the differences in oral anticoagulation (OAC) usage and its impacts.
- It found that among a large group of CABG patients, POAF occurrence ranges between 7.9% and 37.6%, with only 15.5% receiving OAC treatment.
- The results indicate that while thromboembolic events and mortality rates are generally low for POAF patients, OAC use significantly raises the risk of bleeding without reducing thromboembolic or mortality risks compared to non-users.
Article Synopsis
- Atrial fibrillation treatment often requires catheter ablation when medications fail, and this study compares two methods: cryoballoon ablation and pulsed field ablation (PFA).
- Researchers analyzed data from 1,714 patients and found that the cryoballoon method had a significantly higher rate of phrenic nerve palsy and longer procedure durations compared to PFA.
- The results suggest that PFA is safer and more efficient than cryoballoon ablation, with advantages such as faster procedures and no instances of phrenic nerve palsy.
Article Synopsis
- The study aimed to assess the clinical outcomes of using a liberal post-dilatation strategy during percutaneous coronary intervention (PCI).
- It analyzed data from over 10,000 patients before (2015-2017) and after (2018-2020) implementing this strategy, focusing on major adverse cardiovascular events (MACE) and other mortality rates.
- Results showed a significant reduction in 30-day MACE, mortality, and heart attacks following the new strategy, suggesting it may improve patient outcomes after PCI, though further research is needed to confirm these findings.
Objective: The aim of this study was to evaluate the reasons for emergent cardiac surgery (ECS) after transcatheter aortic valve implantation (TAVI) and assess outcomes of these patients.
Methods: All patients undergoing ECS following a complicated TAVI procedure at a high-volume TAVI centre in the Netherlands from 1 January 2008 to 1 April 2022 were included. Baseline and procedural characteristics and outcome data (procedural, 30-day and 1‑year mortality, in-hospital stroke, 30-day pacemaker implantation, 30-day vascular complications, 30-day deep sternal wound infections and 30-day re-exploration) were collected from patient files and analysed using descriptive statistics.
Long-term Outcome of Reexploration for Bleeding After Coronary Artery Bypass Grafting.
J Cardiothorac Vasc Anesth
September 2023
Article Synopsis
- The study investigated how reexploration for bleeding and blood product use after coronary artery bypass grafting (CABG) affects long-term mortality in patients.
- Conducted as a retrospective cohort study at a single center, it included patients who underwent CABG from January 1998 to December 2019, tracking all-cause mortality over a median follow-up period of 9.7 years.
- Results indicated that while reexploration for bleeding didn't significantly impact long-term mortality, the transfusion of packed red blood cells was significantly associated with higher long-term mortality rates.
Background: The differences in outcomes and process parameters for NSTEMI patients who are directly admitted to an intervention centre and patients who are first admitted to a general centre are largely unknown.
Hypothesis: There are differences in process indicators, but not for clinical outcomes, for NSTEMI who are directly admitted to an intervention centre and patients who are first admitted to a general centre.
Methods: We aim to compare process indicators, costs and clinical outcomes of non-ST-segment elevation myocardial infarction (NSTEMI) patients stratified by center of first presentation and revascularisation strategy.
Article Synopsis
- The study evaluated how the quality of life related to atrial fibrillation (AF) at the start impacts major cardiovascular events (MACE) and symptom improvement over a year.
- It followed 970 patients diagnosed with AF in the Netherlands for 12 months, tracking instances of MACE, symptom improvements (EHRA), and hospitalizations.
- Results showed that patients with lower quality of life scores at diagnosis had higher chances of experiencing MACE, improved symptoms, and being hospitalized compared to those with higher quality of life scores, suggesting a need for integrating patient-reported outcomes as prognostic tools.
Background And Objective: Routine outcome monitoring is becoming standard in care evaluations, but costs are still underrepresented in these efforts. The primary aim of this study was therefore to assess if patient-relevant cost drivers can be used alongside clinical outcomes to evaluate an improvement project and to provide insight into (remaining) areas for improvement.
Methods: Data from patients who underwent transcatheter aortic valve implantation (TAVI) between 2013 and 2018 at a single center in the Netherlands were used.
Aims: To investigate the association between the timing of cardiac surgery during pregnancy and both maternal and foetal outcomes.
Methods And Results: Studies published up to 6 February 2021 on maternal and/or foetal mortality after cardiac surgery during pregnancy that included individual patient data were identified. Maternal and foetal mortality was analysed per trimester for the total population and stratified for patients who underwent caesarean section (CS) prior to cardiac surgery (Caesarean section (CaeSe) group) vs.
Heart failure (HF) is a major health concern, which accounts for 1-2% of all hospital admissions. Nevertheless, there remains a knowledge gap concerning which interventions contribute to effective prevention of HF (re)hospitalization. Therefore, this umbrella review aims to systematically review meta-analyses that examined the effectiveness of interventions in reducing HF-related (re)hospitalization in HFrEF patients.
View Article and Find Full Text PDFArticle Synopsis
- This study explores treatment options for patients with significant issues in the left anterior descending coronary artery (LAD), where neither coronary artery bypass grafting (CABG) nor optimal medical therapy (OMT) has clear superiority due to uncertain long-term benefits.
- Conducting a retrospective analysis of 59 patients treated between 2015 and 2020, researchers measured outcomes across both CABG and OMT groups, focusing on mortality, heart attacks, revascularization, and angina severity over a two-year period.
- The findings show no significant differences in the primary and secondary health outcomes between the CABG and OMT groups after two years, suggesting that both treatment methods may be equally effective for
Objectives: The objective of this retrospective study was to assess differences in clinical outcomes between patients on acetylsalicylic acid (ASA) monotherapy and patients on other antithrombotic (AT) regimens undergoing elective coronary artery bypass grafting (CABG).
Methods: Patients who underwent elective isolated CABG between 2017 and 2019 at the Catharina Hospital Eindhoven were eligible for this study. The primary end points were re-exploration for bleeding and postoperative blood product transfusion.
Article Synopsis
- A pregnant woman at 12 weeks gestation underwent urgent heart surgery due to a blockage of her prosthetic valve caused by blood clots.
- The thrombosis occurred because she did not follow the prescribed anticoagulation treatment.
- This case highlights the need for effective anticoagulation management and regular follow-up for patients on such therapies.